CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment

Neurology. 2016 Apr 19;86(16):1553-6. doi: 10.1212/WNL.0000000000002594. Epub 2016 Mar 16.

¹ From the Yale School of Medicine (Y.C., A.N., S.R., G.P., V.L.S.C., A.O.V., D.A.H., D.P.), New Haven, CT; Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (B.A.G.), Cambridge; and University of Nebraska Medical Center (R.Z.), Omaha. yonghao.cao@yale.edu david.pitt@yale.edu.
² From the Yale School of Medicine (Y.C., A.N., S.R., G.P., V.L.S.C., A.O.V., D.A.H., D.P.), New Haven, CT; Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (B.A.G.), Cambridge; and University of Nebraska Medical Center (R.Z.), Omaha.

No abstract available

Publication types